Respiratory syncytial virus (RSV) (Fig. 1) causes a spectrum of respiratory illnesses in infants and young children that may lead to hospitalisations and a substantial number of outpatient visits ...

An insane thing to do while not quite sound of mind you may think – and you’d be right, because it was during one such ...

点击上方“感染学苑” 掌握感染疾病前沿动态9月26日，首都医科大学附属北京儿童医院、国家儿童医学中心、国家呼吸疾病临床研究中心、国家肿瘤监测中心倪鑫教授团队在《The New England Journal of ...

COVID-19, influenza, and respiratory syncytial virus vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025).

Researchers estimate that 123,000 to 193,000 U.S. adults were hospitalized each year with respiratory syncytial virus from ...

Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus Illness,” published in the November 2024 issue ...

PHILADELPHIA--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced new preliminary data for AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) in adults aged 18-49 at increased risk for ...

About 35% of adults got a flu shot, while 18% received the updated COVID-19 vaccine by early November, the CDC report said.

Approximately 1 in 20 adults with outpatient respiratory syncytial virus (RSV) infections were readmitted to the hospital ...

When should pregnant women get the RSV vaccine? Research suggests that 32 weeks into pregnancy ensures the best antibody ...

Seasonal maternal respiratory syncytial virus vaccination and nirsevimab for infants demonstrate cost-effectiveness.